Author:
Lange S.,Son S.,Jensen M.,Medenblik A.,Sullivan J.,Basting E.,Stuart G.
Publisher
Springer International Publishing
Reference8 articles.
1. Center for Disease Control. (2023). HPV Vaccination, The National Immunization Surveys (2008–2021). National Cancer Institute Cancer Trends Progress Report. https://progressreport.cancer.gov/prevention/hpv_immunization.
2. Centers for Disease Control and Prevention. (2021, July 22). HPV treatment. Centers for Disease Control and Prevention. https://www.cdc.gov/std/hpv/treatment.htm#:~:text=There%20is%20no%20treatment%20for,grow%20in%20size%20or%20number.
3. Chesson, H. W., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014, November). The estimated lifetime probability of acquiring human papillomavirus in the United States. Sexually transmitted diseases. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745688/
4. Goldstone, S., et al. (2011, January). Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. Journal of Infectious Disease. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086446/
5. HPV and cancer. National Cancer Institute. (2023, October 18). www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer